Reps. Chaffetz and Cummings, the committee’s chairman and a ranking member, respectively, requested documents containing information on revenue from sales of EpiPens, a life-saving severe allergy treatment, since 2007. The representatives are also seeking information on manufacturing costs and reimbursement Mylan receives from Medicare and Medicaid.
Mylan said Monday it plans to release a generic version of EpiPen for $300, half of the price of the brand name product, in response to mounting pressure and criticism from the public, policymakers and medical organizations.
More articles on supply chain:
FDA approves new flu vaccine
The rise of the unbranded drug ad: 5 things to know
FDA fast tracks experimental drug to treat Parkinson’s
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
